The effect of systemic inflammation on human brain barrier function

Brain, Behavior, and Immunity

Volumn 62, Issue , 2017, Pages 35-40

  Elwood, Elliot ^a   Lim, Zhi ^a   Naveed, Hammad ^a   Galea, Ian ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Albumin; Blood brain barrier; Cerebrospinal fluid; Infection; Inflammation; Systemic

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; BIOLOGICAL MARKER; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DISEASE PREDISPOSITION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RETROSPECTIVE STUDY; AGED; BLOOD; LEUKOCYTE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; BIOMARKERS; BLOOD SEDIMENTATION; BLOOD-BRAIN BARRIER; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SERUM ALBUMIN;

EID: 85014114768     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.10.020     Document Type: Article

References (31)

1. Abbott, N.J., Patabendige, A.A., Dolman, D.E., Yusof, S.R., Begley, D.J., Structure and function of the blood-brain barrier. Neurobiol. Dis. 37 (2010), 13–25.
2. Banks, W.A., Gray, A.M., Erickson, M.A., Salameh, T.S., Damodarasamy, M., Sheibani, N., Meabon, J.S., Wing, E.E., Morofuji, Y., Cook, D.G., Reed, M.J., Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J Neuroinflammation, 12, 2015, 223.
3. Blakeley, J., Irani, D.N., Approach to the patient with abnormal cerebrospinal fluid protein content. Irani, D.N., (eds.) Cerebrospinal Fluid in Clinical Practice, 2009, Saunders, Philadelphia, 287–294.
4. Blyth, B.J., Farhavar, A., Gee, C., Hawthorn, B., He, H., Nayak, A., Stocklein, V., Bazarian, J.J., Validation of serum markers for blood-brain barrier disruption in traumatic brain injury. J. Neurotrauma 26 (2009), 1497–1507.
5. Combrinck, M.I., Perry, V.H., Cunningham, C., Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience 112 (2002), 7–11.
6. Correale, J., Fiol, M., Gilmore, W., The risk of relapses in multiple sclerosis during systemic infections. Neurology 67 (2006), 652–659.
7. Cunningham, C., Wilcockson, D.C., Campion, S., Lunnon, K., Perry, V.H., Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25 (2005), 9275–9284.
8. Denes, A., Ferenczi, S., Kovacs, K.J., Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood-brain barrier damage and brain oedema independently of infarct size. J. Neuroinflammation, 8, 2011, 164.
9. Erickson, M.A., Hartvigson, P.E., Morofuji, Y., Owen, J.B., Butterfield, D.A., Banks, W.A., Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier. J Neuroinflammation, 9, 2012, 150.
10. George, J., Bleasdale, S., Singleton, S.J., Causes and prognosis of delirium in elderly patients admitted to a district general hospital. Age Ageing 26 (1997), 423–427.
11. Hammer, C., Stepniak, B., Schneider, A., Papiol, S., Tantra, M., Begemann, M., Siren, A.L., Pardo, L.A., Sperling, S., Mohd Jofrry, S., Gurvich, A., Jensen, N., Ostmeier, K., Luhder, F., Probst, C., Martens, H., Gillis, M., Saher, G., Assogna, F., Spalletta, G., Stocker, W., Schulz, T.F., Nave, K.A., Ehrenreich, H., Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol. Psychiatry 19 (2014), 1143–1149.
12. Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., Perry, V.H., Systemic inflammation and disease progression in Alzheimer disease. Neurology 73 (2009), 768–774.
13. Hong, S.H., Khoutorova, L., Bazan, N.G., Belayev, L., Docosahexaenoic acid improves behavior and attenuates blood-brain barrier injury induced by focal cerebral ischemia in rats. Exp. Transl. Stroke Med., 7, 2015, 3.
14. Hughes, C.G., Pandharipande, P.P., Thompson, J.L., Chandrasekhar, R., Ware, L.B., Ely, E.W., Girard, T.D., Endothelial activation and blood-brain barrier injury as risk factors for delirium in critically ill patients. Crit. Care Med. 44 (2016), e809–e817.
15. Irani, S.R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M.S., Friese, M.A., Galea, I., Kullmann, D.M., Beeson, D., Lang, B., Bien, C.G., Vincent, A., N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133 (2010), 1655–1667.
16. Jaeger, L.B., Dohgu, S., Sultana, R., Lynch, J.L., Owen, J.B., Erickson, M.A., Shah, G.N., Price, T.O., Fleegal-Demotta, M.A., Butterfield, D.A., Banks, W.A., Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav. Immun. 23 (2009), 507–517.
17. Lopez-Ramirez, M.A., Wu, D., Pryce, G., Simpson, J.E., Reijerkerk, A., King-Robson, J., Kay, O., de Vries, H.E., Hirst, M.C., Sharrack, B., Baker, D., Male, D.K., Michael, G.J., Romero, I.A., MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation. FASEB J. 28 (2014), 2551–2565.
18. McColl, B.W., Rothwell, N.J., Allan, S.M., Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 28 (2008), 9451–9462.
19. Ouimet, S., Kavanagh, B.P., Gottfried, S.B., Skrobik, Y., Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 33 (2007), 66–73.
20. Podjaski, C., Alvarez, J.I., Bourbonniere, L., Larouche, S., Terouz, S., Bin, J.M., Lecuyer, M.A., Saint-Laurent, O., Larochelle, C., Darlington, P.J., Arbour, N., Antel, J.P., Kennedy, T.E., Prat, A., Netrin 1 regulates blood-brain barrier function and neuroinflammation. Brain 138 (2015), 1598–1612.
21. Reiber, H., Flow rate of cerebrospinal fluid (CSF) – a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J. Neurol. Sci. 122 (1994), 189–203.
22. Rosenberg, G.A., Neurological diseases in relation to the blood-brain barrier. J. Cereb. Blood Flow Metab. 32 (2012), 1139–1151.
23. Serres, S., Anthony, D.C., Jiang, Y., Broom, K.A., Campbell, S.J., Tyler, D.J., van Kasteren, S.I., Davis, B.G., Sibson, N.R., Systemic inflammatory response reactivates immune-mediated lesions in rat brain. J. Neurosci. 29 (2009), 4820–4828.
24. Smith, C.J., Emsley, H.C., Gavin, C.M., Georgiou, R.F., Vail, A., Barberan, E.M., del Zoppo, G.J., Hallenbeck, J.M., Rothwell, N.J., Hopkins, S.J., Tyrrell, P.J., Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol., 4, 2004, 2.
25. Takeda, S., Sato, N., Ikimura, K., Nishino, H., Rakugi, H., Morishita, R., Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model. Neurobiol. Aging 34 (2013), 2064–2070.
26. Thompson, E.J., Different blood–CSF barriers. Thompson, E.J., (eds.) Proteins of the Cerebrospinal Fluid: Analysis & Interpretation in the Diagnosis and Treatment of Neurological Disease, 2005, Elsevier, London.
27. Tomkins, O., Friedman, O., Ivens, S., Reiffurth, C., Major, S., Dreier, J.P., Heinemann, U., Friedman, A., Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex. Neurobiol. Dis. 25 (2007), 367–377.
28. Tourtellotte, W.W., Potvin, A.R., Fleming, J.O., Murthy, K.N., Levy, J., Syndulko, K., Potvin, J.H., Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology 30 (1980), 240–244.
29. van Munster, B.C., Korevaar, J.C., Korse, C.M., Bonfrer, J.M., Zwinderman, A.H., de Rooij, S.E., Serum S100B in elderly patients with and without delirium. Int. J. Geriatr. Psychiatry 25 (2010), 234–239.
30. Varatharaj, A., Galea, I., The blood-brain barrier in systemic inflammation. Brain Behav. Immun., 2016.
31. Yang, C.H., Kao, M.C., Shih, P.C., Li, K.Y., Tsai, P.S., Huang, C.J., Simvastatin attenuates sepsis-induced blood-brain barrier integrity loss. J. Surg. Res. 194 (2015), 591–598.